# PMI (Picard Medical, Inc.) - SEC EDGAR Financial Statements

> Picard Medical, Inc. reported $5.33M in revenue and a net loss of $19.79M for the trailing twelve months ended September 30, 2026 (down 81.7% year over year), with a 26.2% gross margin and a -267.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/PMI
- Markdown: https://convexityos.com/fundamentals/PMI.md
- SEC CIK: 0002030617
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:32 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002030617&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $5.33M | -81.7% YoY |
| Operating Income | TTM | -$14.24M | -267.2% margin |
| Net Income | TTM | -$19.79M | -371.2% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $67K | Total debt: $188K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Revenue** | $4.94M | $4.39M |
| Cost of Revenue | $5.14M | $4.50M |
| **Gross Profit** | -$204K | -$112K |
| Research & Development | $3.05M | $3.38M |
| Selling, General & Admin | $10.00M | $10.22M |
| Total Operating Expenses | $13.05M | $13.60M |
| **Operating Income** | -$13.26M | -$13.71M |
| **EBITDA** | -$13.09M | -$13.49M |
| Income Before Tax | -$26.97M | -$21.07M |
| Income Tax Expense | $35K | -$15K |
| **Net Income** | -$27.00M | -$21.05M |
| Basic EPS | -$37.50 | -$149.50 |
| Basic Shares Outstanding | 724.7K | 158.9K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $217K | $2.95M | $1.15M | $1.01M | $1.19M | $2.13M | $620K | -- |
| Cost of Revenue | $122K | $2.34M | $875K | $598K | $1.32M | $2.26M | $978K | -- |
| **Gross Profit** | $95K | $616K | $275K | $411K | -$130K | -$127K | -$358K | -- |
| Research & Development | $321K | $1.37M | $1.90M | $547K | $951K | $743K | $808K | -- |
| Selling, General & Admin | $1.88M | $3.87M | $2.89M | $2.87M | $2.41M | $2.65M | $2.08M | -- |
| Total Operating Expenses | $2.20M | $5.25M | $4.79M | $3.41M | $3.36M | $3.39M | $2.89M | -- |
| **Operating Income** | -$2.10M | -$4.63M | -$4.51M | -$3.00M | -$3.49M | -$3.52M | -$3.25M | -- |
| **EBITDA** | -$2.06M | -$4.58M | -$4.46M | -$2.96M | -$3.45M | -$3.48M | -$3.20M | -- |
| Interest Expense | -- | -- | -- | -- | -- | $2.43M | -- | -- |
| Income Before Tax | -$2.22M | -$5.65M | -$7.62M | -$4.29M | -$10.43M | -$6.72M | -$5.53M | -- |
| Income Tax Expense | $0 | $7.0K | $0 | $4.0K | $0 | $0 | $31K | -- |
| **Net Income** | -$2.22M | -$5.66M | -$7.62M | -$4.29M | -$10.43M | -$6.72M | -$5.56M | -$8.84M |
| Basic EPS | -$0.95 | -$152.50 | -$5.00 | -- | -$9.57 | -$2,119.50 | -$40.00 | -- |
| Basic Shares Outstanding | 2.3M | 37.1K | 1.5M | -- | 1.1M | 3.5K | 159.3K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $7.45M | $96K |
| **Cash & Short-Term Investments** | $7.45M | $96K |
| Accounts Receivable, Net | -- | $513K |
| Inventory | $7.30M | $8.12M |
| **Total Current Assets** | $20.73M | $9.79M |
| Property, Plant & Equipment, Net | $183K | $227K |
| Goodwill | $615K | $615K |
| Intangible Assets | $509K | $596K |
| **Total Non-Current Assets** | $1.82M | $2.31M |
| **Total Assets** | $22.55M | $12.11M |
| Accounts Payable | $2.08M | $5.29M |
| Other Current Liabilities | $499K | $493K |
| **Total Current Liabilities** | $18.70M | $35.33M |
| **Total Non-Current Liabilities** | $64K | $517K |
| **Total Liabilities** | $18.76M | $35.84M |
| **Total Debt (incl. Leases)** | $527K | $434K |
| Common Stock | $0 | $1.0K |
| Retained Earnings | -$76.84M | -$49.84M |
| Accumulated Other Comp. Income | $228K | $278K |
| **Total Stockholders' Equity** | $3.79M | -$44.00M |
| Total Equity | $3.79M | -$44.00M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $67K | $38K | $121K | $7.45M | $2.81M | $410K | $96K |
| **Cash & Short-Term Investments** | $67K | $38K | $121K | $7.45M | $2.81M | $410K | $96K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | $1.30M | $513K |
| Inventory | $6.38M | $5.97M | $7.45M | $7.30M | $6.55M | $7.00M | $8.12M |
| **Total Current Assets** | $7.63M | $7.59M | $9.51M | $20.73M | $11.59M | $9.64M | $9.79M |
| Property, Plant & Equipment, Net | $140K | $162K | $184K | $183K | $169K | $188K | $227K |
| Goodwill | $615K | $615K | $615K | $615K | $615K | $615K | $615K |
| Intangible Assets | $443K | $465K | $487K | $509K | $531K | $553K | $596K |
| **Total Non-Current Assets** | $1.44M | $1.57M | $1.71M | $1.82M | $1.93M | $2.06M | $2.31M |
| **Total Assets** | $9.06M | $9.17M | $11.22M | $22.55M | $13.52M | $11.70M | $12.11M |
| Accounts Payable | $3.50M | $3.32M | $2.71M | $2.08M | $3.12M | $6.37M | $5.29M |
| Other Current Liabilities | $515K | $515K | $499K | $499K | $6.0K | $505K | $493K |
| **Total Current Liabilities** | $7.73M | $7.45M | $12.66M | $18.70M | $5.37M | $45.64M | $35.33M |
| **Total Non-Current Liabilities** | $0 | $0 | $9.0K | $64K | $180K | $295K | $517K |
| **Total Liabilities** | $7.73M | $7.45M | $12.67M | $18.76M | $5.55M | $45.93M | $35.84M |
| **Total Debt (incl. Leases)** | $188K | $311K | $417K | $527K | $616K | $429K | $434K |
| Common Stock | $0 | $0 | $8.0K | $0 | $7.0K | $1.0K | $1.0K |
| Retained Earnings | -$92.34M | -$90.12M | -$84.46M | -$76.84M | -$72.55M | -$62.13M | -$49.84M |
| Accumulated Other Comp. Income | $262K | $269K | $246K | $228K | $230K | $262K | $278K |
| **Total Stockholders' Equity** | $1.33M | $1.72M | -$1.45M | $3.79M | $7.97M | -$54.49M | -$44.00M |
| Total Equity | $1.33M | $1.72M | -$1.45M | $3.79M | $7.97M | -$54.49M | -$44.00M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$27.00M | -$21.05M |
| Depreciation & Amortization | $163K | $226K |
| Stock-Based Compensation | $754K | $886K |
| Change in Receivables | -$120K | $116K |
| Change in Inventory | $390K | -$1.33M |
| Change in Payables | -$3.21M | $2.21M |
| **Operating Cash Flow** | -$15.67M | -$11.87M |
| **Investing Cash Flow** | -- | $0 |
| Common Stock Issued | $15.21M | $0 |
| **Financing Cash Flow** | $27.08M | $11.74M |
| **Net Change in Cash** | $11.36M | -$148K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.22M | -$5.66M | -$7.62M | -$4.29M | -$10.43M | -$6.72M | -$5.56M | -$8.84M |
| Depreciation & Amortization | $44K | $45K | $46K | $40K | $41K | $40K | $42K | -- |
| Stock-Based Compensation | $93K | $1.38M | $165K | $226K | $204K | $183K | $141K | -- |
| Change in Receivables | $470K | -$18K | $27K | $259K | $408K | -$1.29M | $506K | -- |
| Change in Inventory | -$483K | $1.05M | -$321K | -$531K | $266K | $901K | -$246K | -- |
| Change in Payables | $176K | $612K | $632K | -$1.04M | -$3.25M | $850K | $227K | -- |
| **Operating Cash Flow** | -$2.00M | -$1.35M | -$3.80M | -$4.38M | -$6.51M | -$2.54M | -$2.24M | -- |
| Capital Expenditure | $0 | $0 | -$26K | -- | $0 | $0 | $0 | -- |
| **Free Cash Flow** | -$2.00M | -$1.35M | -$3.83M | -- | -$6.51M | -$2.54M | -$2.24M | -- |
| **Investing Cash Flow** | $0 | $0 | -$26K | -- | $0 | $0 | $0 | -- |
| Common Stock Issued | $0 | $0 | $0 | $0 | $13.72M | $985K | $500K | -- |
| **Financing Cash Flow** | $2.03M | $1.25M | -$7.52M | $13.02M | $8.95M | $2.28M | $2.83M | -- |
| **Net Change in Cash** | $29K | -$83K | -$11.33M | $8.64M | $2.40M | -$278K | $592K | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Gross Margin** | -4.1% | -2.6% |
| **Operating Margin** | -268.4% | -312.3% |
| **Net Profit Margin** | -546.6% | -479.5% |
| Return on Equity (ROE) | -712.6% | -- |
| Return on Assets (ROA) | -119.8% | -173.9% |
| Current Ratio | 1.11x | 0.28x |
| Quick Ratio | 0.72x | 0.05x |
| Debt to Equity | 0.14x | -- |
| **Revenue Growth (YoY)** | +12.5% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 26.2% | 18.6% | 7.8% | -4.1% | -- | -- | -- | -- |
| **Operating Margin** | -267.2% | -248.1% | -265.1% | -268.0% | -- | -- | -- | -- |
| **Net Profit Margin** | -371.2% | -444.3% | -530.5% | -545.8% | -- | -- | -- | -- |
| Return on Equity (ROE) | -1487.7% | -1631.3% | -- | -712.6% | -395.9% | -- | -- | -- |
| Return on Assets (ROA) | -218.3% | -305.4% | -259.0% | -119.8% | -233.3% | -233.5% | -- | -173.9% |
| Current Ratio | 0.99x | 1.02x | 0.75x | 1.11x | 2.16x | 0.21x | -- | 0.28x |
| Quick Ratio | 0.16x | 0.22x | 0.16x | 0.72x | 0.94x | 0.06x | -- | 0.05x |
| Debt to Equity | 0.14x | 0.18x | -- | 0.14x | 0.08x | -- | -- | -- |
| **Revenue Growth (YoY)** | -81.7% | +38.6% | +85.5% | -- | +34.7% | +207.1% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
